Cicatricial alopecia [scarring hair loss]

L12_HAIRLOSSSCAR

obsolete_alopecia:

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L66 Cause of death: ICD-10 — L66 2 out of 7 registries used, show all original rules.	259
4. Check minimum number of events None	259
5. Include endpoints L12_PSEUDOPELADE L12_LICHENPLANO L12_FOLLICULITDECALV L12_PERIFOLLICULITCAP L12_FOLLIULERYTH L12_HAIRLOSS_SCARNAS	297
6. Filter based on genotype QC (FinnGen only)	288

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L60-L75
Name in latin: Alopecia cicatrisans

NAME	L12_HAIRLOSSSCAR
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	L12_PSEUDOPELADE\|L12_LICHENPLANO\|L12_FOLLICULITDECALV\|L12_PERIFOLLICULITCAP\|L12_FOLLIULERYTH\|L12_HAIRLOSS_SCARNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L66
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L66
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cicatricial alopecia [scarring hair loss] based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1938	1201	729
Only index persons	1789	1155	634
Unadjusted period prevalence (%)
Whole population	0.03	0.03	0.02
Only index persons	0.04	0.04	0.02
Median age at first event (years)
Whole population	48.69	56.69	35.57
Only index persons	48.37	56.89	32.84

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	288	221	67
Unadjusted period prevalence (%)	0.07	0.08	0.03
Median age at first event (years)	55.69	59.34	43.68

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
297: Matched controls
2970

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L66.1

ICD-10 Finland

Lichen planopilaris

+∞

140.0

123

D07AD01

ATC

clobetasol; topical

13.0

114.7

177

303

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

12.2

88.1

109

135

L66.9

ICD-10 Finland

Cicatricial alopecia, unspecified

+∞

73.0

P01BA02

ATC

hydroxychloroquine; oral

9.6

70.4

103

155

L66.8

ICD-10 Finland

Other cicatricial alopecia

+∞

44.9

70404

ICD-8 Finland

Diseases of hair and hair follicles, Folliculitis NUD

+∞

40.6

L66.2

ICD-10 Finland

Folliculitis decalvans

+∞

35.1

D07AC01

ATC

betamethasone; topical

4.4

34.8

181

780

L30.9

ICD-10 Finland

Dermatitis, unspecified

4.3

31.5

113

368

J01AA04

ATC

lymecycline; systemic

4.6

25.6

192

D10BA01

ATC

isotretinoin; oral

7.1

24.2

D07AC13

ATC

mometasone; topical

3.4

24.0

136

585

L66.0

ICD-10 Finland

Pseudopelade

+∞

21.1

D07XC01

ATC

betamethasone; topical

4.1

20.9

195

E0000UV, ,

ATC

3.1

20.6

170

892

L63.9

ICD-10 Finland

Alopecia areata, unspecified

202.2

18.8

D07AB02

ATC

hydrocortisone butyrate; topical

2.9

17.9

126

595

L43.8

ICD-10 Finland

Other lichen planus

16.6

16.5

H04.10

ICD-10 Finland

Dry eye syndrome

3.3

14.1

226

L66.4

ICD-10 Finland

Folliculitis ulerythematosa reticulata

+∞

12.6

XQ848

NOMESCO Finland

Dermatological photography

8.9

11.5

R06AX27

ATC

desloratadine; oral

2.4

11.4

108

566

L93.0

ICD-10 Finland

Discoid lupus erythematosus

36.6

11.4

XQ845

NOMESCO Finland

Dermatoscopy

13.4

11.3

L71.8

ICD-10 Finland

Other rosacea

26.2

11.2

S01GX01

ATC

cromoglicic acid; ophthalmic

2.5

10.8

409

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

3.0

10.4

203

E000001, ,

ATC

2.5

10.1

363

L43.9

ICD-10 Finland

Lichen planus, unspecified

8.3

9.8

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

4.2

9.4

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

8.4

9.0

D05BB02

ATC

acitretin; oral

8.4

9.0

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

16.9

8.6

L64.9

ICD-10 Finland

Androgenic alopecia, unspecified

92.6

8.5

L64.8

ICD-10 Finland

Other androgenic alopecia

+∞

8.4

S06

ICPC

Rash localized

3.8

8.2

L72.1

ICD-10 Finland

Trichilemmal cyst

4.0

7.2

J01AA07

ATC

tetracycline; systemic

2.3

7.1

279

D06BX01

ATC

metronidazole; topical

2.6

7.1

193

L71.9

ICD-10 Finland

Rosacea, unspecified

7.8

7.0

L04AX03

ATC

methotrexate; systemic

2.7

6.9

163

R06AE07

ATC

cetirizine; oral

1.9

6.5

143

985

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

7.3

6.3

L65.9

ICD-10 Finland

Nonscarring hair loss, unspecified

27.3

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

10.19

56.75

1.4

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

347

3.56

21.37

1.4

422.22

571.22

titre

0.55

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

4.80

14.97

1.2

2.02

3.45

u/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

4.74

14.75

1.2

2.50

3.71

u/ml

0.43

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

4.55

14.40

1.2

3.70

1.04

u/ml

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

4.55

11.56

1.1

1.2

38.86

34.05

u/ml

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

3.91

11.29

2.6

2.2

—

(3006315) Basophils [#/volume] in Blood

183

1223

2.29

10.74

6.2

5.5

0.04

e9/l

0.13

166

1061

(3019198) Lymphocytes [#/volume] in Blood

185

1247

2.28

10.57

6.2

5.6

1.89

2.02

e9/l

0.55

169

1114

(3001604) Monocytes [#/volume] in Blood

182

1219

2.27

10.55

6.2

5.5

0.54

0.55

e9/l

0.20

166

1056

(3013115) Eosinophils [#/volume] in Blood

187

1268

2.28

10.50

6.2

5.7

0.18

e9/l

0.29

172

1112

(40760892) CBC W Ordered Manual Differential panel - Blood

173

1157

2.19

9.78

6.6

6.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

245

1959

2.43

8.01

6.0

7.2

73.41

77.60

u/l

1.21

234

1822

(3000494) Fungus identified in Specimen by Culture

281

2.42

7.85

1.6

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

193

1418

2.03

7.68

7.9

9.1

3.54

3.93

e9/l

2.42

177

1239

(3013707) Erythrocyte sedimentation rate by Westergren method

239

1907

2.30

7.58

4.6

4.0

10.80

11.84

mm/h

0.83

227

1735

(3002030) Lymphocytes/100 leukocytes in Blood

167

1184

1.94

7.17

6.4

5.8

29.75

28.88

0.58

162

1111

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

582

2.02

7.05

1.4

1.2

0.88

1.49

u/ml

0.62

161

(40768804) Tissue Pathology biopsy report

149

1061

1.81

5.91

2.7

2.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

146

1055

1.76

5.34

2.3

83.64

78.17

nmol/l

1.53

130

940

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

239

2004

1.99

5.25

4.7

4.0

14.35

14.78

pmol/l

2.20

219

1820

(3024561) Albumin [Mass/volume] in Serum or Plasma

142

1025

1.74

5.16

3.6

4.2

36.28

35.91

g/l

0.33

127

969

(3002256) Pathology report gross observation

304

2.04

5.02

1.5

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

248

1.96

3.85

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

129

967

1.59

3.70

2.0

1.9

94.69

98.11

pmol/l

0.35

471

(3007164) IgA [Mass/volume] in Serum or Plasma

511

1.65

3.35

1.6

1.5

2.43

2.40

g/l

0.05

302

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

557

1.62

3.26

2.1

2.0

2.65

3.24

mg/l

1.84

481

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

473

1.66

3.23

1.3

13.73

9.95

u/ml

0.16

189

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

125

2.18

3.19

1.0

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

261

2365

1.85

3.07

5.9

4.8

1.75

2.40

mu/l

0.68

245

2155

(3004616) Nuclear Ab [Presence] in Serum

3.34

2.97

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

4.00

2.79

1.4

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

482

1.59

2.77

1.4

1.3

20.60

34.49

iu/ml

1.18

163

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

151

1225

1.47

2.76

5.3

6.5

1.22

mmol/l

0.11

130

1049

(3001122) Ferritin [Mass/volume] in Serum or Plasma

133

1057

1.47

2.68

3.4

2.5

152.86

104.82

ug/l

0.74

121

967

(3021589) Normoblasts [#/volume] in Blood

137

1099

1.46

2.61

9.8

9.0

0.00

e9/l

0.53

114

889

(3048689) Calprotectin [Mass/mass] in Stool

299

1.68

2.53

2.1

104.44

119.57

ug/g

0.23

235

(3030905) Polymorphonuclear cells [#/volume] in Blood

3.05

2.51

4.2

3.0

3.84

4.47

e9/l

0.45

(3023103) Potassium [Moles/volume] in Serum or Plasma

279

2615

2.10

2.50

16.0

14.8

3.93

3.95

mmol/l

0.50

272

2533

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

110

856

1.45

2.42

3.2

3.0

—

(44813793) Dust mix specific IgE antibody measurement

4.19

2.37

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

2.89

2.37

4.1

3.5

54.82

57.08

0.31

(3044889) 12 lead EKG panel

204

1786

1.45

2.32

3.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

197

1716

1.44

2.28

4.8

4.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

277

2604

1.95

2.23

15.9

14.8

139.81

139.84

mmol/l

0.07

268

2528

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

3.06

2.16

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

270

2525

1.76

2.12

14.7

12.7

20.02

21.92

mg/l

0.45

218

1947

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

3.56

2.06

1.1

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

461

1.49

2.05

2.8

2.7

2.44

2.45

mmol/l

0.45

406

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

102

804

1.41

2.03

2.2

2.4

58.68

55.19

u/l

0.57

746

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

2.87

2.01

1.4

1.3

—

nmol/l

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

137

1137

1.38

2.01

4.7

5.6

1.22

mmol/l

0.15

123

1037

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

191

1674

1.40

2.00

2.9

46.14

46.91

u/l

0.04

177

1569

(3035350) Ketones [Presence] in Urine by Test strip

146

1229

1.37

1.94

4.0

3.6

0.00

estimate

0.50

242

(40758558) Short blood count panel - Blood

627

1.43

1.93

5.0

6.6

—

(3030467) Casts [#/volume] in Urine by Automated count

673

1.41

1.92

3.2

2.9

0.31

0.48

e6/l

0.53

492

(3012516) Albumin [Mass/volume] in Urine

692

1.41

1.90

3.0

3.1

32.54

245.89

mg/l

0.88

425

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

273

1.58

1.87

1.8

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

156

1333

1.36

1.86

4.1

6.1

10.34

10.29

umol/l

0.03

145

1268

(3009261) Glucose [Presence] in Urine by Test strip

147

1245

1.36

1.85

4.0

3.6

0.00

estimate

-0.00

217

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

3.58

1.84

5.8

4.8

—

(3002582) Erythrocytes [#/volume] in Urine

733

1.39

1.83

3.1

3.0

13.05

126.67

e6/l

0.68

548

(3015377) Calcium [Moles/volume] in Serum or Plasma

106

854

1.38

1.83

2.6

3.3

2.35

2.36

mmol/l

0.24

747

(3009508) Creatinine [Moles/volume] in Urine

734

1.39

1.81

3.0

7.39

7.25

mmol/l

0.11

619

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

2.62

1.81

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

194

1.67

1.80

1.8

1.6

—

(36660697) Celiac disease serology panel - Serum

195

1.66

1.77

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

103

1.90

1.76

1.3

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

2.55

1.75

1.3

—

nmol/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.97

1.74

1.5

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

496

1.43

1.70

2.8

2.5

5.36

5.60

e6/l

0.07

450

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2.23

1.69

1.8

2.2

0.40

0.36

u/ml

—

(36304419) Bacteria [Presence] in Urine

660

1.38

1.67

3.1

2.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

2.62

1.67

4.8

3.1

—

24.19

—

(3026008) Bacteria identified in Urine by Culture

781

1.36

1.66

2.8

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

2.84

1.66

1.3

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

107

1.83

1.59

4.1

2.2

11.54

13.86

nmol/l

0.70

101

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

169

1.66

1.58

1.1

1.2

150.17

163.18

iu/ml

—

(3021601) Nitrite [Presence] in Urine by Test strip

144

1236

1.32

1.58

5.0

4.8

0.00

estimate

-0.00

222

(3026782) Osmolality of Urine

476

1.41

1.57

2.9

2.7

560.66

532.39

mosm/kgh2o

0.45

408

(3052851) Hemolysis interference index of Serum or Plasma

2.02

1.56

5.5

2.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.37

1.53

1.2

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2.89

1.51

1.2

—

(3008898) HLA-B27 [Presence]

1.84

1.46

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

730

1.33

1.45

3.6

3.7

7.50

8.15

mg/mmol

0.06

431

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

501

1.38

1.44

1.7

1.4

—

(3015736) pH of Urine

118

997

1.30

1.42

3.6

3.4

5.64

5.83

0.41

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

440

1.40

1.42

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

113

952

1.30

1.38

4.4

3.7

—

(40761536) Microorganisms panel - Urine sediment

201

1.55

1.36

3.9

3.6

—

(3018095) Leukocytes [#/volume] in Urine

104

870

1.30

1.33

3.6

3.5

52.99

67.67

e6/l

0.22

593

(3028192) IgG subclass 2 [Mass/volume] in Serum

2.53

1.31

1.7

1.4

2.50

2.89

g/l

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

2.53

1.31

1.7

1.4

7.28

6.20

g/l

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

2.53

1.31

1.7

1.4

0.35

0.28

g/l

—

(4062490) Immunoglobulin typing, IgG

2.53

1.31

2.5

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

251

2363

1.40

1.30

6.3

5.5

38.76

39.46

mmol/mol

0.80

231

2190

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.81

1.29

1.0

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

817

1.30

1.28

2.5

3.0

59.82

29.35

u/l

0.64

777

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.26

1.25

1.6

1.5

—

(1616796) Gas panel - Central venous blood

2.03

1.24

1.6

3.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

370

1.39

1.24

3.0

3.5

0.81

mmol/l

0.03

340

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2.00

1.23

1.6

1.9

6017.00

762.58

u/l

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

254

2401

1.40

1.23

14.8

12.1

83.46

81.49

ml/min/173m2

0.88

218

1940

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

309

1.42

1.23

2.7

2.1

27.50

22.61

1.41

266

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

460

1.35

1.23

3.7

47.32

284.40

ng/l

2.03

354

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.66

1.22

1.4

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.66

1.22

2.2

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

284

1.43

1.20

1.7

2.5

5.45

5.80

umol/l

0.10

249

(40768797) Stomach Pathology biopsy report

372

1.38

1.20

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

1.16

0.0

3.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

2.52

1.15

1.2

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

502

1.32

1.14

1.5

1.7

487.52

452.24

pmol/l

0.39

410

(3024980) IgG subclass 4 [Mass/volume] in Serum

2.03

1.13

1.5

0.49

0.62

g/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

261

2488

1.40

1.11

5.1

4.5

5.83

5.89

mmol/l

0.41

246

2271

(3011397) Hemoglobin [Presence] in Urine by Test strip

579

1.30

1.09

4.3

3.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

121

1.61

1.08

3.2

3.4

1.17

2.32

mmol/l

0.52

(3001019) Free T4 and TSH panel - Serum or Plasma

114

1.62

1.05

1.9

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

158

1422

1.24

1.04

4.0

4.8

6.64

6.63

mmol/l

0.02

151

1310

(3014576) Chloride [Moles/volume] in Serum or Plasma

284

1.39

1.03

6.2

7.3

104.89

104.00

mmol/l

0.77

284

(4200892) Spirometry reversibility

181

1.48

1.02

1.5

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

670

1.27

0.99

5.4

3.9

0.00

estimate

-0.00

222

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

561

1.28

0.95

1.7

1.6

0.82

1.03

mg/l

0.81

451

(3021901) Oxygen saturation in Capillary blood

1.91

0.94

1.6

2.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

134

1.53

0.94

3.2

2.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

667

1.25

0.92

3.4

3.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

564

1.27

0.91

1.4

1.5

22.46

21.74

nmol/l

0.13

474

(3026389) Candida sp identified in Specimen by Organism specific culture

2.09

0.90

1.0

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.88

0.88

2.0

2.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

2.02

0.87

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

126

1124

1.21

0.86

16.3

10.8

1.22

1.17

inr

0.23

320

(3023419) Bacteria identified in Sputum by Culture

1.95

0.85

1.3

2.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.95

0.85

1.3

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

413

1.28

0.83

2.5

2.6

0.84

1.10

e6/l

0.63

212

(3004588) Protein electrophoresis panel - Serum or Plasma

147

1.46

0.82

1.8

2.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.83

0.79

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.79

0.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.79

0.0

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

669

1.23

0.78

2.7

3.1

904.39

884.40

ng/l

0.02

559

(3018418) pH of Serum or Plasma

774

1.21

0.78

3.3

7.39

7.40

0.12

139

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

372

1.28

0.76

2.5

2.7

3.81

3.14

e6/l

0.15

172

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1.72

0.76

1.4

2.4

23.91

25.95

mmol/l

—

(3025130) Human papilloma virus identified in Specimen

1.86

0.74

1.3

1.8

—

(3003694) ABO and Rh group [Type] in Blood

675

0.81

0.73

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.02

0.73

1.4

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

627

1.22

0.72

2.6

5631.18

7849.61

umol/l

0.15

545

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1.55

0.70

1.2

1.4

384.67

314.39

ug/g

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.58

0.69

2.2

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1.87

0.68

3.0

2.9

2.44

3.21

nmol/l

—

(3019225) pH of Specimen

233

1.32

0.68

3.0

4.1

—

(40761511) CBC panel - Blood by Automated count

271

2634

1.33

0.67

13.9

12.0

—

(3042936) Bacteria identified in Isolate by Culture

333

1.27

0.67

1.5

2.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

285

2792

1.51

0.67

23.4

19.2

40.49

40.05

0.80

263

2615

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1.80

0.66

1.0

—

0.97

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1.80

0.66

1.0

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

167

1558

1.16

0.62

3.4

2.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

429

1.23

0.62

1.5

1.6

985.43

1233.32

nmol/l

1.20

316

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

309

1.26

0.62

3.5

4.3

24.39

21.63

0.43

142

(3020191) Ethanol [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.2

—

1.38

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.52

0.59

1.0

1.6

—

(1002224) Polysomnography panel

106

1.44

0.59

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

141

1.37

0.58

3.7

3.4

4.27

4.54

pmol/l

0.63

119

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.49

0.57

1.5

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.56

0.56

1.6

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.49

0.54

1.0

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.47

0.53

2.0

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.55

0.53

1.0

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

162

1.32

0.51

1.5

1.3

—

39.74

—

(40761535) Cells panel - Urine sediment

198

1.29

0.51

3.0

3.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

180

1.30

0.51

1.5

2.4

67.83

67.33

g/l

0.12

166

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

154

1.32

0.50

1.6

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1.53

0.48

2.3

1.5

0.67

0.83

nmol/l

—

(3021440) Promyelocytes/100 leukocytes in Blood

201

1.27

0.46

5.5

4.6

0.17

0.09

—

(3013512) EKG study

743

1.14

0.44

4.9

3.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.43

0.43

1.5

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.40

0.43

1.9

2.1

—

(3044640) Blood type and Crossmatch panel - Blood

774

1.14

0.43

2.5

2.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

259

1.22

0.42

1.3

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.57

0.42

1.0

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.57

0.42

1.0

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.37

0.42

2.1

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

324

0.82

0.41

4.8

4.4

35.29

31.62

1.06

215

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.52

0.41

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.52

0.41

1.4

2.1

—

(3028433) Virus identified in Specimen by Culture

0.00

0.41

0.0

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1.41

0.41

1.5

2.3

275.27

281.89

ug/l

0.01

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

260

2540

1.19

0.41

5.3

4.4

4.77

4.80

mmol/l

0.20

245

2354

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

307

1.20

0.41

6.0

6.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.3

—

(3045788) Cell count panel - Pleural fluid

0.00

0.41

0.0

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

264

2583

1.20

0.40

5.6

5.0

2.83

mmol/l

0.03

248

2379

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.5

—

0.87

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

0.00

0.40

0.0

1.2

—

34588.18

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.32

0.40

1.3

1.5

—

(40768806) Pleura Pathology biopsy report

0.00

0.39

0.0

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

0.00

0.39

0.0

1.2

—

2013.00

—

(3012441) Differential panel - Pleural fluid

0.00

0.39

0.0

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

740

1.13

0.39

1.8

1.6

1.30

1.41

mmol/l

0.85

625

(3003740) Influenza virus B Ag [Presence] in Specimen

1.36

0.37

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.36

0.37

1.2

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

217

1.22

0.37

5.3

4.4

0.71

0.91

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.37

0.36

1.9

—

(3022313) Gas panel - Capillary blood

1.35

0.36

4.1

3.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.47

0.36

1.0

1.4

—

(3000330) Specific gravity of Urine by Test strip

126

1.29

0.36

2.5

3.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

108

1.31

0.36

1.8

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

274

0.83

0.34

1.7

1.9

—

(4034850) Laboratory test

0.67

0.33

3.7

8.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

273

0.83

0.33

1.7

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

324

1.16

0.32

1.3

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

222

1.19

0.30

1.8

2.1

0.20

0.22

g/l

0.66

208

(3013139) Helicobacter pylori Ag [Presence] in Stool

163

0.79

0.30

1.2

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.28

0.30

4.4

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.26

0.29

1.1

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.23

0.29

3.7

1.7

5.64

4.58

mmol/24h

—

(4035726) Immunohistochemistry procedure

233

1.17

0.28

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

172

0.80

0.28

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

1.24

0.27

1.4

2.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

197

1.18

0.26

5.3

4.6

0.20

0.35

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.20

0.26

1.3

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

593

1.10

0.25

2.5

2.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

133

1.21

0.25

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

237

1.15

0.24

2.0

3.0

1.11

0.73

ug/l

0.36

153

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.32

0.23

2.0

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.32

0.23

2.8

3.9

15.40

92.02

u/ml

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

219

1.15

0.23

2.7

1.9

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.29

0.23

1.0

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.29

0.23

1.0

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1.29

0.23

1.2

2.1

—

(3045424) Erythrocytes [Presence] in Urine

1.29

0.23

1.0

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.75

0.23

1.4

1.5

—

(3021788) Differential panel - Synovial fluid

1.25

0.22

1.2

1.8

—

(3022145) Colonoscopy Study observation

296

1.13

0.22

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

256

2521

1.11

0.22

5.0

4.4

1.51

1.54

mmol/l

0.64

240

2325

(21494755) Public health laboratory ask at order entry panel

220

1.15

0.22

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

201

1.16

0.22

2.5

1.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.19

0.21

1.0

9.0

—

138.38

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.21

0.0

1.6

—

127.27

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

2.8

—

(3035880) pH of Pleural fluid

0.00

0.21

0.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

2.8

—

(40765096) Chromosome analysis panel by Banding

0.00

0.21

0.0

1.3

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

0.00

0.21

0.0

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.21

0.0

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

183.51

—

(3025577) Chromium [Mass/volume] in Blood

0.00

0.21

0.0

2.5

—

1.81

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.21

0.0

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.21

0.0

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.17

0.21

1.0

5.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.17

0.21

1.4

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

0.00

0.21

0.0

3.1

—

50.75

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

9.92

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.6

—

1.57

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

68.56

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

17.22

—

(3000492) Spirometry study

218

0.86

0.20

1.6

1.4

—

(3045414) Leukocytes [Presence] in Urine

109

1.20

0.19

1.9

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.13

0.19

1.0

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.19

0.18

1.0

1.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.15

0.17

1.0

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

1.15

0.17

2.6

2.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.74

0.17

1.6

1.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.16

0.16

1.5

1.2

—

(1761868) Lipid panel - Serum or Plasma

943

1.06

0.15

2.9

2.8

—

(3019060) Gas panel - Arterial blood

150

0.86

0.15

1.6

7.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

393

1.08

0.14

2.0

1.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

122

1.15

0.14

1.9

2.3

0.03

0.14

e6/l

2.25

115

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

246

2431

1.07

0.13

4.8

3.9

1.31

1.27

mmol/l

0.34

231

2228

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

219

1.10

0.13

1.2

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

120

1171

1.04

0.10

2.7

2.4

—

(3019150) Specific gravity of Urine by Refractometry

546

1.05

0.10

4.8

4.0

1.01

1.02

kg/l

—

(3022621) pH of Urine by Test strip

166

0.90

0.10

1.9

2.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.14

0.10

1.8

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.14

0.10

1.0

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

248

0.92

0.10

1.7

1.8

—

(3012544) pH of Venous blood

207

0.91

0.10

7.2

3.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.11

0.10

1.0

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.04

0.08

1.8

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

246

0.93

0.08

3.7

3.1

—

(3002032) Base excess in Venous blood by calculation

205

0.92

0.08

7.2

3.1

0.16

2.32

mmol/l

2.11

173

(3016879) Cocaine [Presence] in Urine

1.06

0.08

1.7

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.06

0.08

1.3

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.03

0.08

1.9

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.83

0.07

1.0

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

143

0.90

0.07

1.8

—

(3000991) Gas panel - Venous blood

186

1.08

0.07

14.1

8.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.86

0.07

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.87

0.07

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.87

0.07

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

265

0.94

0.07

1.7

1.8

1.31

1.46

0.70

234

(3023368) Bacteria identified in Blood by Culture

598

0.96

0.06

3.8

4.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

121

0.91

0.06

1.4

2.2

1.35

1.30

0.04

121

(3003396) Base excess in Arterial blood by calculation

267

1.05

0.05

6.5

9.4

0.01

1.33

mmol/l

1.44

221

(3014111) Lactate [Moles/volume] in Serum or Plasma

212

0.94

0.05

8.9

6.6

1.15

1.25

mmol/l

0.46

206

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

943

1.03

0.05

4.1

3.4

21.85

30.90

ng/l

0.67

641

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

120

0.91

0.05

6.3

12.5

—

(3025941) Bacteria identified in Stool by Culture

130

0.92

0.04

1.0

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

108

0.92

0.03

2.6

2.8

64.72

48.90

—

108

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

117

0.94

0.02

1.4

2.2

0.51

0.65

1.05

117

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

376

0.98

0.00

1.7

1.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

139

1.01

0.00

1.6

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

241

1.00

0.00

4.2

2.4

1.71

1.76

0.13

217

(3021879) Hepatitis B virus core Ab [Presence] in Serum

164

0.97

0.00

1.3

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

0.00

0.0

1.3

—

1.68

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

17.65

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.5

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

0.0

1.0

—

7.20

—

(3006462) Nitrate [Presence] in Urine

0.00

0.0

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

0.0

1.7

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

110.71

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.0

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.0

1.8

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.00

0.0

3.2

—

82.80

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

0.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.0

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.2

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.0

1.0

—

2.96

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.0

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3020891) Body temperature

0.95

0.00

1.4

4.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.00

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1.00

-0.00

1.2

4.2

—

3.71

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.92

-0.00

1.2

1.6

—

(40768793) Breast Pathology biopsy report

0.94

-0.00

1.3

—

(3028300) Cannabinoids [Presence] in Urine

0.99

-0.00

1.7

1.3

—

(3044007) Cell count panel - Peritoneal fluid

0.00

-0.00

0.0

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.02

-0.00

2.0

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

0.99

-0.00

1.7

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.00

-0.00

2.3

3.8

—

(3034426) Prothrombin time (PT)

0.00

-0.00

0.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

0.99

-0.00

1.7

1.2

—

(3027008) Opiates [Presence] in Urine

0.99

-0.00

1.7

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.02

-0.00

2.0

1.5

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

-0.00

0.0

2.3

—

54.78

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.00

-0.00

1.3

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.94

-0.00

2.0

2.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_HAIRLOSSSCAR and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_HAIRLOSSSCAR	1.016 [0.78, 1.33]	0.91
Birth year	0.996 [0.99, 1.0]	0.377

During the follow-up period (1.1.1998 — 31.12.2019), 71 out of 867 females with L12_HAIRLOSSSCAR died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_HAIRLOSSSCAR.

N-year risk	Females	Males
1	0.114%	No data
5	0.624%	No data
10	1.506%	No data
15	3.054%	No data
20	5.469%	No data

Relationships between endpoints

↥

Index endpoint: L12_HAIRLOSSSCAR – Cicatricial alopecia [scarring hair loss]

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cicatricial alopecia [scarring hair loss]

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints